30th AMLI ANNUAL MEETING 2017

 

PLENARY SESSION 1

New Roles for an Old Entity:

the Complement System

Sunday, August 13, 8:30 am - 12:00 noon

Chaired by:

Ashley Frazer-Abel, Ph.D. and Maria Alice Willrich, Ph.D.

8:30 - 9:10

Introduction to Complement System and Laboratory Testing

Maria Alice Willrich, Ph.D., Mayo Clinic

9:10 - 9:50

C3 Glomerulopathy - New Breakthroughs and Old Challenges

Joshua M.Thurman, M.D., University of Colorado School of Medicine

10:10 - 10:50

The Role of Complement in Atypical Hemolytic Uremic Syndrome

and Paroxysmal Nocturnal Hemoglobinuria

Meera Sridharan, M.D., Ph.D., Mayo Clinic

10:50 - 11:20

Complement Therapeutics: Reality and Perspectives

Ashley Frazer-Abel, Ph.D., D(ABMLI), Exsera BioLabs, University of Colorado School of Medicine

11:20 - Noon

Case Presentation and Round-Table Discussion

Moderated by Ashley Frazer-Abel, Ph.D. and Maria Willrich, Ph.D.

 

PLENARY SESSION 2

Updates in Autoimmunity: ANCA

Sunday, August 13, 2:00 pm - 5:00 pm

Chaired by:

M. Qasim Ansari, M.D. and Colleen J. Lewis, Ph.D., D(ABMLI)

2:00-2:15

ANCA-Associated Vasculitis: Introduction and a Case Study

Colleen J. Lewis, Ph.D., D(ABMLI), Quest Diagnostics Nichols Institute

2:15-3:05

Laboratory Methods for ANCA Detection - Extreme Diversity in Practice

M. Qasim Ansari, M.D., Cleveland Clinic Lerner College of Medicine

3:15-4:15

Update on ANCA-Associated Vasculitis

Carol Langford, M.D., MHS, Center for Vasculitis Care and Research, Cleveland Clinic

4:15-5:00

Panel Discussion and Question and Answer Session

Colleen Lewis, Ph.D., M. Qasim Ansari, M.D., and Carol Langford, M.D., MHS

 

PLENARY SESSION 3

Vaccination and Vaccine Response Assessment

in Primary and Acquired Immune Deficiencies

Monday, August 14, 8:30 am - 12:00 noon

Chaired by:

Vijaya Knight, M.D., Ph.D., and Roshini Abraham, Ph.D.

 

8:30-9:00

Challenges in PID: The Good, the Bad, the Ugly

Erwin Gelfand, M.D., National Jewish Health

9:00 - 9:30

Understanding and Assessing the Vaccination Response in Immunocompromised Patients

Pia Johanna Hauk, M.D., National Jewish Health

9:30 - 10:00

Live Attenuated Vaccines in Cellular Immune Deficiency Post Bone Marrow Transplant

Elena Hsieh, M.D., University of Colorado Denver

10:30 - 11:00

Measuring Immune Responses to Pneumococcal Vaccines

Moon Nahm, M.D., University of Alabama at Birmingham; WHO Pneumococcal Reference Laboratory; NIH Bacterial Respiratory Pathogen Reference Laboratory

11:00 - 11:30

Can the Measurement of Typhim Vi IgG Be Used to Assess the Response to

Polysaccharide Vaccines?

Antony Parker, Ph.D., The Binding Site Group

 

PLENARY SESSION 4

Aging and the Immune System

Tuesday, August 15, 8:30 am - 12:00 noon

Chaired by:

Amir A. Sadighi Akha, M.D., D.Phil. and Lisa K. Peterson, Ph.D.

8:30 - 9:10

Aging and the Immune System: An Overview

Amir A. Sadighi Akha, M.D., D.Phil., Mayo Clinic

9:10 - 10:00

Novel Pathways of Aging and Inflammation

Daniel R. Goldstein, M.D., University of Michigan Medical School

10:20 - 11:10

T Cell Aging - Mechanisms and Biomarkers

Jörg J. Goronzy, M.D., Ph.D., Stanford University School of Medicine

11:10 - noon

Aging, Inflammation and Poor B Cell Response

Bonnie B. Blomberg, Ph.D., University of Miami Miller School of Medicine

 

 PLENARY SESSION 5

The Molecular  Revolution in the Clinical Laboratory and Beyond

Wednesday, August 16, 8:30 am - 12:00 noon

Chaired by:

Kevin Goudy, Ph.D.and Eric T. Weimer, Ph.D.

8:30 - 9:15 

Molecular Diagnostics in the Clinical Laboratory: Win, Lose or Draw

Kevin Goudy, Ph.D., CSI Laboratories

9:15 - 10:00  

Antibody Repertoire and Influenza Immunity

Ian York, DVM, M.Sc., Ph.D., Centers for Disease Control and Prevention

 

                                              10:30 - 11:15                                                

Clonal Tracking of Genetically Engineered Human Immune and Hematopoietic Cells

Through Integration Sites Analysis

Luca Biasco, Ph.D., Dana-Farber/Boston Children’s Cancer and Blood Disorders Center;

UCL Great Ormond Street Institute of Child Health

                                                              11:15 - Noon                                                                          

Cell-free DNA as a Transplant Rejection Biomarker

Eric T. Weimer, Ph.D., University of North Carolina at Chapel Hill School of Medicine

 

 
 


 

 

Back